Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
TG Therapeutics, Inc. (TGTX) had Debt to Capital Ratio of 0.27 for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$616.29M |
|
$447.18M |
|
$100.71M |
|
$515.57M |
|
$492.96M |
|
$123.32M |
|
$-15.93M |
|
$107.39M |
|
$107.39M |
|
$447.18M |
|
$447.18M |
|
$447.18M |
|
$447.18M |
|
$123.32M |
|
$121.00M |
|
144.32M |
|
161.41M |
|
$3.10 |
|
$2.77 |
|
| Balance Sheet Financials | |
$630.76M |
|
-- |
|
$432.49M |
|
$1.06B |
|
$153.76M |
|
$245.65M |
|
$261.47M |
|
$415.23M |
|
$648.02M |
|
$648.02M |
|
$648.02M |
|
155.31M |
|
| Cash Flow Statement Financials | |
$-24.77M |
|
$13.80M |
|
$-89.73M |
|
$181.19M |
|
$80.49M |
|
$-100.70M |
|
$64.67M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.10 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.27 |
0.38 |
|
83.66% |
|
20.01% |
|
20.01% |
|
19.63% |
|
17.43% |
|
72.56% |
|
$-24.99M |
|
-- |
|
-- |
|
-- |
|
0.58 |
|
0.80 |
|
2.02 |
|
181.01 |
|
69.01% |
|
69.01% |
|
42.06% |
|
50.04% |
|
$4.17 |
|
$-0.15 |
|
$-0.15 |
|